Bank Of America Corp Sarepta Therapeutics, Inc. Transaction History
Bank Of America Corp
- $1.19 Trillion
- Q3 2024
A detailed history of Bank Of America Corp transactions in Sarepta Therapeutics, Inc. stock. As of the latest transaction made, Bank Of America Corp holds 783,029 shares of SRPT stock, worth $96.6 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
783,029
Previous 721,401
8.54%
Holding current value
$96.6 Million
Previous $114 Million
14.2%
% of portfolio
0.01%
Previous 0.01%
Shares
13 transactions
Others Institutions Holding SRPT
# of Institutions
529Shares Held
84.2MCall Options Held
2.06MPut Options Held
1.52M-
Black Rock Inc. New York, NY10.3MShares$1.27 Billion0.04% of portfolio
-
Vanguard Group Inc Valley Forge, PA8.97MShares$1.11 Billion0.02% of portfolio
-
Capital International Investors Los Angeles, CA6.26MShares$772 Million0.16% of portfolio
-
Janus Henderson Group PLC London, X04.36MShares$538 Million0.29% of portfolio
-
State Street Corp Boston, MA4.27MShares$527 Million0.02% of portfolio
About Sarepta Therapeutics, Inc.
- Ticker SRPT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 87,567,904
- Market Cap $10.8B
- Description
- Sarepta Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapeutics, gene therapies, and other genetic therapeutic modalities for the treatment of rare diseases. It offers EXONDYS 51 injection to treat duchenne muscular dystrophy (duchenne) in patients with confirmed mut...